NCT01018823 - A Multiple Dose Study Of Ertugliflozin (PF-04971729, MK-8835) In Otherwise Healthy Overweight And Obese Volunteers (MK-8835-037) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 14, 2009

Primary Completion Date

March 18, 2010

Study Completion Date

March 18, 2010

Conditions

Healthy Volunteer

Interventions

DRUG

Ertugliflozin

Ertugliflozin oral dosing 1 mg, 5 mg, 25 mg, or 100 mg solutions/suspensions administered once daily for 14 days immediately after breakfast

DRUG

Placebo to Ertugliflozin

Placebo oral dosing solutions/suspensions administered once daily for 14 days immediately after breakfast